JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131499

Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody

3

(1 Review)

|

(36 Publications)

Rabbit Polyclonal JNK1 phospho Y185 + T183 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Rat, Human, Mouse samples. Cited in 36 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK8 phospho Y185 + T183.

View Alternative Names

JNK1, PRKM8, SAPK1, SAPK1C, MAPK8, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, JNK-46, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, SAPK1c

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)

Immunofluorescence analysis of methanol fixed HeLa cells labelled with ab131499 at 1/100 dilution.

Western blot - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)
  • WB

Unknown

Western blot - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (AB131499)

Secondary antibody - anti-rabbit HRP (ab6721)

All lanes:

Western blot - Anti-JNK1 + JNK2 (phospho T183 + Y185) antibody (ab131499) at 1/500 dilution

Lane 1:

C6 cells treated with anisomycin

Lane 2:

Untreated C6 cells

Predicted band size: 48 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human, Mouse

Applications

IHC-P, WB, ICC/IF

applications

Immunogen

Synthetic Peptide within Human MAPK8 phospho Y185 + T183. The exact immunogen used to generate this antibody is proprietary information.

P45983

Specificity

The region of JNK1 and JNK2 surrounding T183 + Y185 has a high degree of similarity to the corresponding regions in JNK3 and thus may cross react with this protein if phosphorylated on the corresponding residues.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This antibody was purified by affinity chromatography using epitope-specific phosphopeptide. Non-phosphospecific antibodies were removed by chromatography using non-phosphopeptide.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

JNK1 and JNK2 are part of the c-Jun N-terminal kinase group also called Stress-activated protein kinases (SAPKs). These proteins are serine/threonine kinases with a known molecular weight around 46-54 kDa depending on their phosphorylation state. JNK1 and JNK2 phosphorylate specific target proteins which include transcription factors and other kinases to regulate various cellular processes. They are expressed in most tissues with higher levels in brain heart and skeletal muscle. JNK isoforms have become essential in research involving stress responses where specific tools such as JNK antibodies and Western blot assays targeting p-JNK molecular weight are critical for study.
Biological function summary

These enzymes play vital roles in regulating cellular responses to stress stimuli. JNK1 and JNK2 form part of larger signaling complexes including the JNK molecular weight complex that is activated in stressful conditions like UV radiation or cytokines. Once activated they phosphorylate transcription factors such as c-Jun leading to gene expression changes that facilitate adaptative and survival responses. They modulate cellular processes like apoptosis inflammation and cell differentiation clearly contributing to homeostasis and development.

Pathways

These kinases interact significantly within the MAPK (Mitogen-activated protein kinase) and apoptosis pathways. JNK proteins mediate signals from upstream kinases such as MKK4/7 and respond to inflammatory cytokines resulting in transcriptional alterations. Their downstream impact is tightly linked to apoptosis through interactions with Bcl-2 family members affecting cellular fate. ERK and p38 MAPK proteins closely interact with JNK pathways co-regulating cellular stress responses and survival pathways highlighting their importance in maintaining cellular balance.

The altered regulation of JNK1 and JNK2 links them to diverse conditions such as cancer and neurodegenerative diseases. In cancer abnormal JNK activity affects cell proliferation and apoptosis with JNK pathways often hyperactivated in tumors. In neurodegeneration these kinases contribute to cell death as seen in disorders like Alzheimer's disease where they engage with proteins like tau leading to neuronal apoptosis. The connection of JNK proteins to other stress-activated kinases further positions them as critical therapeutic targets in disease modulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed : 28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed : 18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed : 21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed : 21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed : 21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed : 21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed : 18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed : 16581800, PubMed : 17296730, PubMed : 20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed : 22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed : 10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed : 22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed : 22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed : 27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed : 28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed : 34048572).. JNK1 isoforms display different binding patterns : beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.
See full target information MAPK8 phospho Y185 + T183

Publications (36)

Recent publications for all applications. Explore the full list and refine your search

Journal of neuroinflammation 21:178 PubMed39034417

2024

PEDF-34 attenuates neurological deficit and suppresses astrocyte-dependent neuroinflammation by modulating astrocyte polarization via 67LR/JNK/STAT1 signaling pathway after subarachnoid hemorrhage in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Wu,Yanchao Liu,Qiuguang He,Guangnan Ao,Ningbo Xu,Wangqing He,Xiao Liu,Lei Huang,Qian Yu,Hideki Kanamaru,Siyuan Dong,Shiyi Zhu,Ye Yuan,Mingyang Han,Yeping Ling,Lu Liu,Chenyu Wu,You Zhou,Prativa Sherchan,Jerry J Flores,Jiping Tang,Xionghui Chen,Xuying He,John H Zhang

Cytotechnology 76:153-166 PubMed38495298

2024

Evodiamine ameliorates intervertebral disc degeneration through the Nrf2 and MAPK pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Tian Xie,Xi Gu,Ruijie Pan,Wenzhuo Huang,Sheng Dong

Life sciences 327:121856 PubMed37307966

2023

Arjunolic acid modulate pancreatic dysfunction by ameliorating pattern recognition receptor and canonical Wnt pathway activation in type 2 diabetic rats.

Applications

Unspecified application

Species

Unspecified reactive species

Khurram Aamir,Gautam Sethi,Mst Rejina Afrin,Chowdhury Faiz Hossain,Patricia Regina Jusuf,Satyajit D Sarker,Aditya Arya

Clinical immunology (Orlando, Fla.) 245:109176 PubMed36368640

2022

Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Zewei Sun,Wenjing Chen,Zhen Wang,Shuai Wang,Jie Zan,Liangrong Zheng,Wenting Zhao

International journal of molecular sciences 23: PubMed36077357

2022

Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.

Applications

Unspecified application

Species

Unspecified reactive species

Eduardo E Vargas-Pozada,Erika Ramos-Tovar,Juan D Rodriguez-Callejas,Irina Cardoso-Lezama,Silvia Galindo-Gómez,Daniel Talamás-Lara,Verónica Rocío Vásquez-Garzón,Jaime Arellanes-Robledo,Víctor Tsutsumi,Saúl Villa-Treviño,Pablo Muriel

Evidence-based complementary and alternative medicine : eCAM 2022:1612829 PubMed35990822

2022

Protective Effects of Platycodin D3 on Airway Remodeling and Inflammation via Modulating MAPK/NF-B Signaling Pathway in Asthma Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Peng,Fengchun Xiao,Long Lin

Neurochemical research 47:3167-3177 PubMed35842555

2022

Exogenous TIPE2 Inhibit TAK1 to Improve Inflammation and Neuropathic Pain Induced by Sciatic Nerve Injury Through Inactivating NF-κB and JNK.

Applications

Unspecified application

Species

Unspecified reactive species

Xuehua Sun,Xinyou Li,Youfei Zhou,Yufei Wang,Xiaochen Liu

International journal of molecular sciences 23: PubMed35887045

2022

Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Yangwenshu Liu,Qin Kuang,Xianling Dai,Minxia Zhan,Li Zhou,Liancai Zhu,Bochu Wang

Journal of neuroinflammation 19:129 PubMed35658977

2022

DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Long-Qing Zhang,Shao-Jie Gao,Jia Sun,Dan-Yang Li,Jia-Yi Wu,Fan-He Song,Dai-Qiang Liu,Ya-Qun Zhou,Wei Mei

Bosnian journal of basic medical sciences 22:217-228 PubMed34813418

2022

Protocatechuic acid as an inhibitor of the JNK/CXCL1/CXCR2 pathway relieves neuropathic pain in CCI rats.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Xia Chang,Yue-Feng Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com